Review





Similar Products

anti p synapsin1  (Cell Signaling Technology Inc)
86
Cell Signaling Technology Inc anti p synapsin1
Anti P Synapsin1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p synapsin1/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
anti p synapsin1 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
anti synapsin1  (Cell Signaling Technology Inc)
86
Cell Signaling Technology Inc anti synapsin1
Anti Synapsin1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti synapsin1/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
anti synapsin1 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
human synapsin1 promoter  (Addgene inc)
93
Addgene inc human synapsin1 promoter
Human Synapsin1 Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human synapsin1 promoter/product/Addgene inc
Average 93 stars, based on 1 article reviews
human synapsin1 promoter - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
human synapsin1 promoter hsyn1p  (Addgene inc)
93
Addgene inc human synapsin1 promoter hsyn1p
MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the <t>synapsin1-driven</t> GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).
Human Synapsin1 Promoter Hsyn1p, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human synapsin1 promoter hsyn1p/product/Addgene inc
Average 93 stars, based on 1 article reviews
human synapsin1 promoter hsyn1p - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
anti-synapsin1  (Synaptic Systems)
90
Synaptic Systems anti-synapsin1
MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the <t>synapsin1-driven</t> GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).
Anti Synapsin1, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-synapsin1/product/Synaptic Systems
Average 90 stars, based on 1 article reviews
anti-synapsin1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
anti-synapsin1/2  (Synaptic Systems)
90
Synaptic Systems anti-synapsin1/2
MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the <t>synapsin1-driven</t> GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).
Anti Synapsin1/2, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-synapsin1/2/product/Synaptic Systems
Average 90 stars, based on 1 article reviews
anti-synapsin1/2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
guinea pig synapsin1 antibody  (Synaptic Systems)
90
Synaptic Systems guinea pig synapsin1 antibody
MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the <t>synapsin1-driven</t> GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).
Guinea Pig Synapsin1 Antibody, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/guinea pig synapsin1 antibody/product/Synaptic Systems
Average 90 stars, based on 1 article reviews
guinea pig synapsin1 antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
synapsin1  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc synapsin1
MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the <t>synapsin1-driven</t> GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).
Synapsin1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/synapsin1/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
synapsin1 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

Image Search Results


MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the synapsin1-driven GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).

Journal: iScience

Article Title: TAOK2 controls synaptic plasticity and anxiety via ERK and calcium signaling

doi: 10.1016/j.isci.2025.113712

Figure Lengend Snippet: MAPK and calcium signaling is reduced in Taok2 cKO neurons (A–D) Luciferase assay using EGR1p (A), SARE- (B), FOSBp- (C), and CRE- (D) sensor-detected MAPK (A–C) and calcium (B, D)-dependent signaling activity in primary cortical neurons. Neurons were treated with AMPA (1 μM), BDNF (10 ng/mL), or bicuculline (BIC, 1 μM) on day in vitro 12 (DIV12) for 4 h. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; n.s., not significant; Student’s t test (two-sided). (E) Imaging of control and Taok2 cKO primary cortical neurons infected with AVVs expressing the synapsin1-driven GCaMP6f calcium sensor. Images were taken before and after stimulating cells with 25 mM KCl. (F) Quantification of cellular GCaMP6f responses to 25 mM KCl. Intensities from responding cells were normalized to the background and pooled for analysis. Gray arrowheads on the x axis represent the time points at which images were taken before and after stimulation as shown in (E). The line represents the mean, and the shaded area represents the SEM; n = 30 responding cells from two independent cultures. ∗∗∗ p < 0.001 and mixed ANOVA. (G) Western blots indicate reduced phosphorylated Mek1/2 (p-Mek1/2) and Erk1/2 (p-Erk1/2) in primary mouse cortical neurons. Neurons were treated with AMPA (1 μM) on DIV12 for 4 h. (H and I) Quantification of western blot data shown in (G). Data of p-Erk1/2 are relative to total Erk1/2 (H), and data of p-Mek1/2 are relative to total Mek1/2 (I). Values are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001; Wilcoxon rank-sum test (two-sided).

Article Snippet: On DIV6, half the medium was changed and the neurons were infected with AAVs for expression of mRuby2-P2A-GCaMP6f under the control of the human synapsin1 promoter (hSyn1p) (Addgene #50943) at an MOI of 1000.

Techniques: Luciferase, Activity Assay, In Vitro, Imaging, Control, Infection, Expressing, Western Blot